Social Mixer 2024 Singapore
marketing interactive Content360 Singapore 2024 Content360 Singapore 2024
CNN Philippines puts out statement distancing from fabricated news claim

CNN Philippines puts out statement distancing from fabricated news claim

share on

CNN Philippines has put out a statement separating itself from a fabricated source of news. According to the brand, there was a use of unauthorised online posts in its website linking the news organisation to medical products and health claims. The issue first arose late last year after a fabricated CNN Philippines report made the rounds on Facebook, promoting a treatment called "glucosoft" for diabetes.

The network said that it is taking action against the sources of these online posts and websites using the company brand and assets illegally. “The CNN Philippines brand equates to accurate, fair, and balanced reporting. The news network pursues these journalistic traits in all its content,” said CNN in a statement. According to reports on AFP, the fabricated post on Facebook also read, "A genius student from the Philippines received the highest national medical award for discovering a treatment for diabetes. No matter how many years of diabetes, it will take effect as soon as you use it, and the blood glucose will be stabilised without recurrence!"

According to AFP, CNN Philippines told them that they are “in no way connected to the medicine brand which supposedly cures diabetes”.  

Related articles: 

CNN criticised for 'unethical' reporting of Thailand childcare mass shooting
Donald Trump files US$475m defamation lawsuit against CNN
CNN and Samsung join hands to encourage sustainable future with technology

share on

Follow us on our Telegram channel for the latest updates in the marketing and advertising scene.
Follow

Free newsletter

Get the daily lowdown on Asia's top marketing stories.

We break down the big and messy topics of the day so you're updated on the most important developments in Asia's marketing development – for free.

subscribe now open in new window